Sutro Biopharma, Inc 10-K for FY2025
Sutro Biopharma, Inc. (STRO)
10-K
2026-03-23
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
Sutro Biopharma, Inc filed this 10-K on March 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $102.48M
- up 65.2% from $62.04M a year earlier
- Net loss
- $191.09M
- compared with a net loss of $227.46M a year earlier
- Diluted EPS
- -$22.49
- compared with -$29.40 a year earlier